BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 38438972)

  • 1. Development and validation of nomogram to predict overall survival and disease-free survival after surgical resection in elderly patients with hepatocellular carcinoma.
    Tian Y; Wang Y; Wen N; Lin Y; Liu G; Li B
    Front Oncol; 2024; 14():1395740. PubMed ID: 38854717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and Validation of a Blood Test-based Nomogram to Diagnose Patients with AFP-negative HCC.
    Wu Y; Liu S; Fan Z; Tian Y; Zhang L; Liu S
    Curr Cancer Drug Targets; 2024; 24(5):556-564. PubMed ID: 38178672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of serum STIP1 in HCC and AFP-negative HCC.
    Sun H; Liu N; Lou J
    Lab Med; 2024 May; ():. PubMed ID: 38780206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram and calculator for predicting the prognosis of patients with giant hepatocellular carcinoma.
    Chen W; Cheng S
    Expert Rev Anticancer Ther; 2024 Jun; ():1-8. PubMed ID: 38874538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a nomogram for predicting in-hospital survival rates of patients with COVID-19.
    Bai WH; Yang JJ; Liu Z; Ning WS; Mao Y; Zhou CL; Cheng L
    Heliyon; 2024 May; 10(10):e31380. PubMed ID: 38803927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1.
    He M; Liang C; Pang Y; Jiang M; Long M; Yao Z; Wang X; Zhang R; Wu Q; Liang S; Li J
    J Hepatocell Carcinoma; 2024; 11():913-925. PubMed ID: 38799002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Novel Prognostic Nomogram Based on Platelet and CD8
    Shi W; Yan H; Liu X; Yu L; Xie Y; Wu Y; Liang Y; Yang Z
    J Hepatocell Carcinoma; 2024; 11():1049-1063. PubMed ID: 38863997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatocellular carcinoma risk in patients with HBV-related cirrhosis: a competing risk nomogram based on a 4-year retrospective cohort study.
    Guo D; Li J; Zhao P; Mei T; Li K; Zhang Y
    Front Oncol; 2024; 14():1398968. PubMed ID: 38817899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
    Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
    Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
    Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
    BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of web
    Zhan G; Cao P; Peng H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
    Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
    Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study.
    Hao S; Luo R; Li W; Zhao R; Qi T; Wang Z; Li N; Liu M
    BMC Gastroenterol; 2023 Jun; 23(1):207. PubMed ID: 37312022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.
    Zhou D; Liu X; Wang X; Yan F; Wang P; Yan H; Jiang Y; Yang Z
    BMC Cancer; 2021 Mar; 21(1):246. PubMed ID: 33685417
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.